Research graph
References from Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons. Local targets link to admitted publications; unresolved targets remain external evidence.
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
10.1182/blood-2016-01-643569 · 2016 · External reference
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
10.1182/blood.2022015851 · 2022 · External reference
Definitive radiotherapy for localized follicular lymphoma staged by
10.1182/blood-2018-04-843540 · 2019 · External reference
Unresolved reference
External reference
Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the
10.3389/fonc.2021.796962 · 2021 · External reference
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute
10.1002/1097-0142(19821215)50:12<2699::aid-cncr2820501202>3.0.co;2-a · 1982 · External reference
Follicular lymphoma: 2018 update on diagnosis and management
10.1002/ajh.24937 · 2018 · External reference
Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical)
10.2967/jnumed.122.264106 · 2023 · External reference
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023
10.6004/jnccn.2023.0057 · 2023 · External reference
Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma-experience at the Lymph Node Registry Kiel
10.1007/s00277-016-2704-0 · 2016 · External reference
Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey
10.1182/blood.2022015520 · 2022 · External reference
Diagnosing Lymphoproliferative Disorders Using Core Needle Biopsy Versus Surgical Excisional Biopsy: Three-Year Experience of a Reference Center in Lebanon
10.1016/j.clml.2019.11.013 · 2020 · External reference
Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes
10.1111/j.1600-065x.1998.tb01446.x · 1998 · External reference
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma
10.1080/10428194.2022.2140281 · 2023 · External reference
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
10.1056/nejmoa012914 · 2002 · External reference
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
10.1038/35000501 · 2000 · External reference
A predictive model for aggressive non-Hodgkin’s lymphoma
10.1056/nejm199309303291402 · 1993 · External reference
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
10.1182/blood-2006-08-038257 · 2007 · External reference
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin’s lymphomas. Groupe d’Etudes des Lymphomes de l’Adulte (GELA)
1998 · External reference
Follicular lymphoma international prognostic index
10.1182/blood-2003-12-4434 · 2004 · External reference
The natural history of initially untreated low-grade non-Hodgkin’s lymphomas
10.1056/nejm198412063112303 · 1984 · External reference
Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type
10.1093/annonc/mdn760 · 2009 · External reference
Hodgkin lymphoma, version 2.2015
10.6004/jnccn.2015.0075 · 2015 · External reference
Unresolved reference
2023 · External reference
Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis
10.1186/s13045-022-01281-9 · 2022 · External reference
The role of radiotherapy in Hodgkin’s lymphoma: what has been achieved during the last 50 years?
10.1155/2015/485071 · 2015 · External reference
Impact of risk factors on outcomes in early-stage Hodgkin’s lymphoma: an analysis of international staging definitions
10.1093/annonc/mdt413 · 2013 · External reference
A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease
10.1056/nejm199811193392104 · 1998 · External reference
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496
10.1111/bjh.12222 · 2013 · External reference
Report of the Committee on Hodgkin’s Disease Staging Classification
1971 · External reference
Revised response criteria for malignant lymphoma
10.1200/jco.2006.09.2403 · 2007 · External reference
Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma
10.1056/nejmoa1000067 · 2010 · External reference
Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma
10.1056/nejmoa1408648 · 2015 · External reference
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
10.1056/nejmoa1510093 · 2016 · External reference
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin’s disease: report of an intergroup trial
10.1200/jco.2003.12.086 · 2003 · External reference
Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma
10.1182/blood-2017-05-784678 · 2017 · External reference
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
10.6004/jnccn.2018.0013 · 2018 · External reference
Rituximab: the first monoclonal antibody approved for the treatment of lymphoma
10.2174/1389201003379059 · 2000 · External reference
Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma
10.1056/nejm199512073332305 · 1995 · External reference
Unresolved reference
External reference
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · External reference
Updated Diagnostic Criteria and Staging System for Multiple Myeloma
10.1200/edbk_159009 · 2016 · External reference
Multiple myeloma
10.1056/nejmra041875 · 2004 · External reference
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel
10.1186/s13045-017-0549-1 · 2018 · External reference
How I treat AL amyloidosis
10.1182/blood.2020008737 · 2022 · External reference
Bone marrow immunohistology of plasma cell neoplasms
10.1136/jcp.56.6.406 · 2003 · External reference
mutated and wild-type Waldenström’s Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in
10.3324/haematol.2018.190181 · 2018 · External reference
Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens
10.1309/bvt4-yp41-lcv2-5gt0 · 2001 · External reference
Expression of PRAD1/cyclin D1 in plasma cell malignancy: incidence and prognostic aspects
10.1046/j.1365-2141.1999.01204.x · 1999 · External reference
Karyotype in multiple myeloma and plasma cell leukaemia
10.1016/0959-8049(93)90071-m · 1993 · External reference
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
10.1200/jco.2015.61.2267 · 2015 · External reference
Unresolved reference
External reference
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy
10.1016/j.ccr.2013.12.015 · 2014 · External reference
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group
10.1016/j.ijrobp.2018.05.009 · 2018 · External reference
10.1016/j.rx.2020.07.006
10.1016/j.rx.2020.07.006 · External reference
A review for solitary plasmacytoma of bone and extramedullary plasmacytoma
10.1100/2012/895765 · 2012 · External reference
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia
10.1200/jco.19.00394 · 2019 · External reference
Biology, prognosis, and therapy of waldenström macroglobulinemia
10.1007/978-3-319-13150-4_7 · 2015 · External reference
Ileo-colonic lymphoma: presentation, diagnosis, and management
10.1097/mog.0000000000000687 · 2021 · External reference
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma
10.1093/neuonc/noy192 · 2019 · External reference
Orthopedic surgical management of skeletal complications of malignancy
10.1002/(sici)1097-0142(19971015)80:8+<1614::aid-cncr12>3.0.co;2-2 · 1997 · External reference
